Population-based survey of SARS-CoV-2 infection and immune response
- Funded by National Institutes of Health (NIH)
- Total publications:9 publications
Grant number: 3R01AI143875-02S1
Grant search
Key facts
Disease
COVID-19Start & end year
20202021Known Financial Commitments (USD)
$5,429,240Funder
National Institutes of Health (NIH)Principal Investigator
AARON JULIUS SIEGLERResearch Location
United States of AmericaLead Research Institution
EMORY UNIVERSITYResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
To have an optimal response to the COVID-19 epidemic, it is important to understand the proportion of adultsin the United States may have the virus that causes COVID-19, and how many have had it in the past and mayhave immunity. Currently available data are limited because the impact of asymptomatic and mildlysymptomatic cases is unclear and many people are unable to access a test due to rationing, or may beotherwise unwilling to go for testing or care. This study will address this problem by conducting a nationalprobability sample, where each address may be selected by chance, to develop estimates of the proportion ofadults in the United States that are infected with the virus that causes COVID-19, and the proportion that hashad the disease in the past and may now have immunity. We will use home-based testing techniques tofacilitate participation in this national study. We will also use surveys to better understand participants in oursample. With these estimates, we will conduct disease modeling to understand different scenarios of theepidemic. We will also develop a website to provide information and data to the public.
Publicationslinked via Europe PMC
Last Updated:14 hours ago
View all publications at Europe PMC